About

 

BioFormatix, Inc. is a research, product development, and service company focusing on the needs of biomedical markets. Our technology addresses complex problems in data collection, data modeling, and software development.

 

The current product development programs include:

We continue to support the VFExpertTM (GSP - Glaucoma Staging Program) product, which is diagnostic aid software for the early detection of glaucoma based on the results of the visual field test.

 

 

NEWS FLASH Sept 2, 2011. BioFormatix receives a grant award from the National Cancer Institute for development of novel technology for ultrasensitive detection of biomarkers of ovarian cancer in blood.